Silicone Breast Implants Armpit Incision in Chula Vista CA
Breast augmentation, or augmentation mammoplasty, is one of the most common plastic surgery procedure performed today. Over time, factors such as age, genetics, pregnancy, weight changes, sun exposure, and gravity can cause the size and shape of the breast to change. Women who are dissatisfied with the size of their breasts, or have experienced changes in breast appearance can achieve a fuller, shapelier breast with breast augmentation. During breast augmentation, a breast implant is placed inside a pocket formed in the breast tissue. This can help to increase or balance the size of the breast, restore breast volume, or restore the shape of the breast after partial or total loss. It is important to realize that breast augmentation cannot correct significantly sagging or drooping breasts. In these instances, a breast lift is often necessary, which may be performed in conjunction with this procedure.
Re-approved by the FDA in 2006, silicone implants are made of a silicone rubber shell and are filled with silicone gel. There is no significant evidence that suggests silicone implants increase your risk for breast cancer, connective tissue disorders, or autoimmune disease. You must be at least 22 years old to receive silicone implants. Breast implants differ by shape, texture, or profile. Breast implants may be round or contoured, and may have a smooth or textured surface. The breast implant profile may be standard, moderate, and high. Lastly, breast implants vary by size, or volume. The type, style, and size of breast implants you choose are determined by your lifestyle, body contours, the amount of breast tissue you have, and the cup size and appearance that you would like to achieve. Be sure to talk with your doctor in depth about choosing the breast implant option that is right for you.
The breast consists of glands and milk ducts, surrounded by fatty tissue which provides its shape and soft form. The elasticity of your skin also contributes to its shape. As you know, certain factors such as age and pregnancy can affect the elasticity of your skin and breast tissue, which results in changes to shape and appearance.
Breast implants can be placed in two general locations, known as submuscular and subglandular placement. Submuscular placement refers to an implant that is placed partially or completely beneath the pectoralis muscle, against the chest wall. In contrast, subglandular placement refers to an implant that is placed beneath the breast tissue, but above the pectoralis muscle. Your surgeon will help determine the implant placement that is best for you.
Breast augmentation procedures typically last approximately one to two hours. Prior to the start of your procedure the treatment area will be thoroughly cleansed and an anesthetic will be administered. Depending on the surgeon’s preferences and the nature of the procedure, a local anesthetic in combination with intravenous sedation or general anesthesia will be used.
The transaxillary incision is placed in the natural fold of the armpit; therefore there will be no scar on the breast. A small incision is made inside each armpit. Using an instrument known as a retractor, the surgeon will open the incision in order to gain better access to the breast tissue below. Although the incision will be made as inconspicuously as possible, its length and appearance may vary depending on the type and size of implant, your body contours, and the surgeon’s preference.
The surgeon will carefully separate the breast tissue with a minimally invasive cautery device and a scalpel, in order to reach the area of the breast in which the pocket will be formed. Using an instrument known as an elevator and their fingers, the surgeon will carefully create a pocket in which to place the breast implant.
Unlike saline implants, which are usually inserted empty, silicone implants are pre-filled. As silicone implants are pre-filled, they generally require a slightly larger incision than saline implants. The surgeon will insert the implant into the pocket and visually inspect your breasts to ensure that they are symmetric. They may adjust the pocket and the position of the breast implant itself to ensure that the desired look is achieved.
The incisions will be closed using sutures in the breast tissue. Sutures, skin adhesive or surgical tape may be used to close the skin. Your surgeon may choose to use non-dissolving sutures, which will be removed in seven to ten days. The scars from the incisions will fade slowly over several months, but it may take up to a year for them to refine completely. As with any surgery, you will most likely experience some pain and swelling after surgery. The majority of the swelling will likely subside within a few days. However, some swelling may persist for several weeks.
Your physician may place you in a special bra or compression garment to aid in the healing process. Compression garments provide support and comfort, minimize swelling, and help to maintain the position of the implants. This is why it is important that you wear the compression garment as recommended by your physician.
You will most likely be able to return to work within three to seven days after your procedure. However, it is important that you avoid any strenuous activity and lifting for approximately three to four weeks. Doing so may delay healing and could damage the implants. You will be able to notice the final results from your procedure once the implants have settled and the swelling has subsided completely.
It is important to realize that your breasts will continue to change shape over time. However, the results from breast augmentation are typically long-lasting, which means that your breasts will maintain the fuller, shapelier appearance that you desire for years to come.
More Chula Vista info...
Chula Vista Sleep
Best Western Chula Vista Inn, 946 Broadway, ? +1 619 691-6868 (fax: +1 619 420-6975), [1].
Best Western South Bay Inn & RV Park, 710 E Street, ? +1 619 420-5183 (toll free: +1 800 420-0041, fax: +1 619 420-6254), [2].
Chula Vista Get out This article is an outline and needs more content. It has a template, but there is not enough information present. Please plunge forward and help it grow!
Plastic Surgery News...
- BioSpace has reported briefly on Phase III data for retigabine, a first-in-class neuronal potassium channel opener which is in development as an adjunct in the treatment of adult epilepsy patients with refractory partial-onset seizures.
The double-blind trial – RESTORE 1 (Retigabine Efficacy and Safety Trials for Partial Onset Epilepsy) – randomised 306 adults who were experiencing refractory partial-onset seizures despite receiving stable doses of up to three anti-epileptics to additional treatment with retigabine (400mg TDS; n=151) or placebo (n=150). Study duration was 32 weeks including 8 weeks baseline phase, 6 weeks titration phase, 12 weeks maintenance phase and 6 weeks transition phase. Only brief details of the study are included in the BioSpace abstract which prevents a full evaluation of the findings; however the following results were reported:
• The median reduction in 28-day total partial seizure frequency was 44.3% in the retigabine group and 17.5% in the placebo group (p<0.0001)
• The median reduction in 28-day total partial seizure frequency during the maintenance phase was 54.5% versus 18.9%, respectively (p<0.0001)
• The responder rate (at least a 50% reduction in 28-day total partial seizure frequency) was 45.0% versus 18.0%, respectively (p<0.0001)
• The responder rate during the maintenance phase was 55.5% versus 22.6%, respectively (p<0.0001)
Results from RESTORE 2, the second pivotal Phase III clinical trial studying lower doses of retigabine, are expected during the second quarter of 2008. The company anticipate filing a Marketing Authorization Application (MAA) to the EMEA before the end of the year.
- The RPSGB has issued a press release in response to a research article published in the Lancet, which calls for the oral contraceptive pill to be made available to women over-the-counter (OTC). The release states that the Society would support such a proposal, as community pharmacies are easily accessible and pharmacists “have clinical skills and expertise that can help them provide information and advice to women to ensure the appropriate use of oral contraception” (see link above for further information).
The Health Minister Lord Darzi recently announced a pilot scheme involving the supply of contraceptive pills by pharmacists in England through Patient Group Directions (PGD; see link above for related NeLM news item)